FR2327781A2 - Nouveau derive anthranilique, son procede de preparation et son applica - Google Patents
Nouveau derive anthranilique, son procede de preparation et son applicaInfo
- Publication number
- FR2327781A2 FR2327781A2 FR7531258A FR7531258A FR2327781A2 FR 2327781 A2 FR2327781 A2 FR 2327781A2 FR 7531258 A FR7531258 A FR 7531258A FR 7531258 A FR7531258 A FR 7531258A FR 2327781 A2 FR2327781 A2 FR 2327781A2
- Authority
- FR
- France
- Prior art keywords
- anthranilate
- quinolyl
- trifluoromethylthio
- dihydrochloride
- dimethylaminoethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000202 analgesic effect Effects 0.000 title 1
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- -1 dimethylaminoethyl trifluoromethylthio-quinolyl-anthranilate dihydrochloride Chemical compound 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- QRXCEWRNIIGMSL-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-[[8-(trifluoromethylsulfanyl)quinolin-4-yl]amino]benzoate Chemical compound CN(C)CCOC(=O)C1=CC=CC=C1NC1=CC=NC2=C(SC(F)(F)F)C=CC=C12 QRXCEWRNIIGMSL-UHFFFAOYSA-N 0.000 abstract 1
- SHYNHMQFJMXLCD-UHFFFAOYSA-N 2-aminobenzoic acid;dihydrochloride Chemical compound Cl.Cl.NC1=CC=CC=C1C(O)=O SHYNHMQFJMXLCD-UHFFFAOYSA-N 0.000 abstract 1
- 208000006820 Arthralgia Diseases 0.000 abstract 1
- 208000008035 Back Pain Diseases 0.000 abstract 1
- 208000008930 Low Back Pain Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 208000025747 Rheumatic disease Diseases 0.000 abstract 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 abstract 1
- 229960002887 deanol Drugs 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 230000003387 muscular Effects 0.000 abstract 1
- 230000000552 rheumatic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000005853 β-dimethylaminoethyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7531258A FR2327781A2 (fr) | 1975-10-13 | 1975-10-13 | Nouveau derive anthranilique, son procede de preparation et son applica |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7531258A FR2327781A2 (fr) | 1975-10-13 | 1975-10-13 | Nouveau derive anthranilique, son procede de preparation et son applica |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2327781A2 true FR2327781A2 (fr) | 1977-05-13 |
FR2327781B2 FR2327781B2 (enrdf_load_stackoverflow) | 1978-08-25 |
Family
ID=9161117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7531258A Granted FR2327781A2 (fr) | 1975-10-13 | 1975-10-13 | Nouveau derive anthranilique, son procede de preparation et son applica |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2327781A2 (enrdf_load_stackoverflow) |
-
1975
- 1975-10-13 FR FR7531258A patent/FR2327781A2/fr active Granted
Also Published As
Publication number | Publication date |
---|---|
FR2327781B2 (enrdf_load_stackoverflow) | 1978-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS145091A3 (en) | Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application | |
NO944249L (no) | Transdermal administrering av oksybutynin | |
DE69532961D1 (de) | Verwendung von porphyrine in der behandlung von multiple sklerose | |
DE69330032D1 (de) | Therapeutisches kombinationspräparat enthaltend interferon | |
NO990279D0 (no) | Isobutylgaba og dets derivater for behandling av smerte | |
DK0513702T3 (da) | Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering | |
ATE287271T1 (de) | Verwendung von vegf zur herstellung eines medikaments zur behandlung oder verhinderung der intimalen hyperplasie und verabreichungsgerät | |
DE60138547D1 (de) | Topisch anwendbare arzneipräparate und verfahren zur behandlung | |
DE69428523D1 (de) | Verfahren zur behandlung von gemüts- oder geisteskrankheiten und von gemüts- oder geisteskrankheiten, die von anfällen begleitet sind | |
MC2078A1 (fr) | Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires | |
SE7502341L (sv) | N-1(1-bensylpyrollidinyl-2-alkyl)-substituerade bensylamider samt förfarande för framställning därav | |
DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
ATE193648T1 (de) | Antipyretische und analgetische verfahren und zusammensetzungen, die optisch reines r-etodolac enthalten | |
FR2327781A2 (fr) | Nouveau derive anthranilique, son procede de preparation et son applica | |
FR2417494A1 (fr) | Nouvelles compositions analgesiques et antipyretiques contenant un derive de paracetamol | |
Phillips | Collaboration with one's client. | |
CN211535628U (zh) | 一种全砭石艾灸罐 | |
AT351667B (de) | Geraet zur therapeutischen behandlung und aktiven massage von muskeln | |
ES361664A1 (es) | Procedimiento para la preparacion de nuevo acido antrani- lico. | |
JP2001288077A (ja) | カプサイシンを利用した慢性前立腺炎、前立腺肥大症、痔疾及び勃起不全治療剤 | |
RU2161477C2 (ru) | Способ профилактики рецидива язвенной болезни двенадцатиперстной кишки | |
RU94042022A (ru) | Лекарственное средство для лечения ишемии мозга | |
RU94002982A (ru) | Способ лечения остеоартроза | |
SU718107A1 (ru) | Способ лечени больных гипоталамическим синдромом вегетативно-сосудистой формы | |
DE3772764D1 (de) | Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl)-methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung. |